
  
    
      
        Background_NNP
        Glaucoma_NNP is_VBZ a_DT prevalent_JJ group_NN of_IN retinal_JJ and_CC optic_JJ nerve_NN
        neuropathies_NNS that_WDT currently_RB renders_NNS approximately_RB 67_CD
        million_CD people_NNS worldwide_NN at_IN risk_NN for_IN developing_VBG significant_JJ
        vision_NN loss_NN ,_, including_VBG blindness_NN [_NN 1_CD ]_NN ._. Glaucoma_NNP involves_VBZ
        the_DT death_NN of_IN retinal_JJ ganglion_NN cells_NNS (_( RGCs_NNP )_) and_CC their_PRP$ axons_NNS ,_,
        and_CC is_VBZ characterized_VBN by_IN atrophic_JJ excavation_NN of_IN the_DT optic_JJ
        nerve_NN [_NN 2_CD ,_, 3_CD ,_, 4_CD ]_NN ._. Glaucoma_NNP is_VBZ usually_RB associated_VBN with_IN high_JJ
        intraocular_JJ pressure_NN (_( IOP_NNP )_) resulting_VBG from_IN an_DT increased_VBN
        resistance_NN to_TO drainage_NN of_IN aqueous_JJ humor_NN ._. Not_RB all_DT people_NNS
        with_IN high_JJ IOP_NNP develop_VB glaucoma_NN [_NN 5_CD ]_NN ,_, however_RB ,_, suggesting_VBG
        that_IN other_JJ factors_NNS ,_, such_JJ as_IN genetic_JJ susceptibility_NN to_TO
        pressure-induced_JJ damage_NN ,_, interact_NN with_IN IOP_NNP to_TO cause_VB damage_NN ._.
        The_DT occurrence_NN of_IN glaucomatous_JJ damage_NN in_IN individuals_NNS
        without_IN high_JJ IOP_NNP and_CC the_DT benefit_NN of_IN lowering_VBG IOP_NNP in_IN some_DT of_IN
        these_DT individuals_NNS further_JJ suggest_VBP multiple_JJ factors_NNS
        determine_VBP an_DT individual_NN 's_POS susceptibility_NN to_TO
        pressure-induced_JJ damage_NN [_NN 6_CD ]_NN ._. The_DT nature_NN of_IN the_DT factors_NNS
        participating_VBG in_IN glaucomatous_JJ events_NNS ,_, particularly_RB those_DT
        influencing_VBG disease_NN progression_NN and_CC modifying_VBG disease_NN
        severity_NN in_IN different_JJ individuals_NNS ,_, remain_VB largely_RB unknown_JJ ._.
        Increased_VBN understanding_NN of_IN factors_NNS contributing_VBG to_TO glaucoma_NN
        will_MD suggest_VB new_JJ therapeutic_JJ strategies_NNS and_CC will_MD likely_RB
        lead_VB to_TO improved_VBN clinical_JJ management_NN ._.
        Glaucomatous_NNP phenotypes_NNS have_VBP been_VBN observed_VBN in_IN a_DT number_NN
        of_IN mammalian_JJ species_NNS ,_, including_VBG mice_NNS [_NN 7_CD ,_, 8_CD ,_, 9_CD ]_NN ._. Mice_NNS can_MD
        be_VB clinically_RB and_CC histologically_RB analyzed_VBD throughout_IN the_DT
        course_NN of_IN a_DT disease_NN and_CC their_PRP$ genes_NNS can_MD be_VB altered_VBN to_TO study_VB
        the_DT molecular_JJ framework_NN underlying_VBG pathology_NN [_NN 10_CD ]_NN ._. As_IN a_DT
        consequence_NN ,_, mouse_NN models_NNS are_VBP useful_JJ for_IN identifying_VBG and_CC
        characterizing_VBG the_DT effects_NNS of_IN causative_JJ genes_NNS necessary_JJ for_IN
        glaucoma_NN development_NN ,_, and_CC for_IN characterizing_VBG the_DT genes_NNS and_CC
        molecular_JJ pathways_NNS that_WDT participate_VBP in_IN or_CC modify_VB disease_NN
        progression_NN [_NN 9_CD ]_NN ._. A_DT collection_NN of_IN glaucomatous_JJ mouse_NN
        strains_NNS with_IN phenotypic_JJ differences_NNS would_MD facilitate_VB
        research_NN to_TO understand_VB the_DT complexity_NN of_IN glaucoma_NN ._. As_IN part_NN
        of_IN our_PRP$ efforts_NNS to_TO understand_VB glaucoma_NN ,_, we_PRP are_VBP screening_VBG for_IN
        and_CC characterizing_VBG glaucoma_NN in_IN aged_VBN mice_NNS of_IN various_JJ
        strains_NNS ._. We_PRP are_VBP particularly_RB interested_JJ in_IN documenting_VBG
        differences_NNS in_IN glaucoma_NN phenotypes_NNS between_IN strains_NNS of_IN mice_NNS
        that_WDT share_NN the_DT same_JJ causative_JJ genes_NNS ._. This_DT information_NN will_MD
        provide_VB an_DT experimental_JJ basis_NN for_IN identifying_VBG genes_NNS and_CC
        mechanisms_NNS that_WDT modify_VB the_DT progression_NN or_CC severity_NN of_IN
        glaucoma_NN ._. Here_RB we_PRP report_VBP differences_NNS in_IN genetic_JJ
        susceptibility_NN to_TO glaucoma-associated_JJ phenotypes_NNS between_IN
        two_CD related_VBN inbred_JJ strains_NNS of_IN mice_NNS ,_, AKXD-_NNP 28_CD /_NN Ty_NNP (_( AKXD_NNP 28_CD )_) and_CC
        DBA_NNP /_NN 2_CD J_NNP (_( D_NNP 2_LS )_) ._.
        D_NNP 2_CD mice_NNS develop_VBP glaucoma_NN involving_VBG a_DT harmful_JJ increase_NN of_IN
        IOP_NNP followed_VBN by_IN RGC_NNP loss_NN and_CC optic_JJ nerve_NN damage_NN [_NN 11_CD ]_NN ._. The_DT
        increase_NN in_IN IOP_NNP is_VBZ associated_VBN with_IN an_DT iris_NNS disease_NN
        involving_VBG iris_NNS pigment_NN dispersion_NN (_( IPD_NNP )_) ,_, iris_NNS stromal_NN
        atrophy_NN (_( ISA_NNP )_) ,_, and_CC the_DT formation_NN of_IN synechiae_NN that_WDT block_VBP
        aqueous_JJ humor_NN drainage_NN ._. The_DT iris_NNS pigment_NN dispersion_NN and_CC
        iris_NNS stromal_NN atrophy_NN phenotypes_NNS are_VBP caused_VBN by_IN distinct_JJ
        recessive_JJ alleles_NNS at_IN the_DT 
        ipd_NN and_CC 
        isa_NN loci_NN ,_, respectively_RB [_NN 12_CD ]_NN ._. The_DT IPD_NNP
        phenotype_NN in_IN D_NNP 2_CD mice_NNS is_VBZ similar_JJ to_TO human_JJ pigment_NN dispersion_NN
        syndrome_NN ,_, a_DT condition_NN that_WDT often_RB leads_VBZ to_TO pigmentary_JJ
        glaucoma_NN [_NN 12_CD ,_, 13_CD ]_NN ,_, and_CC involves_VBZ degeneration_NN of_IN the_DT iris_NNS
        pigment_NN epithelium_NN [_NN 12_CD ,_, 14_CD ]_NN ._. Causative_NNP genes_NNS for_IN pigment_NN
        dispersion_NN remain_VB to_TO be_VB identified_VBN [_NN 12_CD ,_, 15_CD ]_NN ._. The_DT gene_NN
        responsible_JJ for_IN the_DT ISA_NNP phenotype_NN is_VBZ tightly_RB linked_VBN to_TO the_DT
        tyrosinase_NN related_VBD protein_NN 1_CD gene_NN (_( 
        Tyrp_NNP 1_LS )_) [_NN 12_CD ]_NN ,_, which_WDT also_RB regulates_VBZ
        coat_NN color_NN ._. D_NNP 2_CD mice_NNS have_VBP a_DT mutant_JJ allele_NN of_IN this_DT gene_NN (_( 
        Tyrp_NNP 1_CD b_SYM )_) and_CC a_DT brown_JJ coat_NN color_NN [_NN
        16_CD ]_NN ._. In_IN previously_RB studied_VBN genetic_JJ backgrounds_NNS ,_,
        homozygosity_NN for_IN D_NNP 2_CD alleles_NNS of_IN both_DT 
        isa_NN and_CC 
        ipd_NN results_NNS in_IN iris_NNS atrophy_NN that_WDT
        severely_RB affects_VBZ both_DT the_DT iris_NNS stroma_NN and_CC iris_NNS pigment_NN
        epithelium_NN ,_, leading_VBG to_TO a_DT severely_RB atrophic_JJ and_CC largely_RB
        transparent_JJ iris_NNS in_IN old_JJ mice_NNS [_NN 11_CD ,_, 12_CD ]_NN ._.
        AKXD_NNP 28_CD is_VBZ a_DT recombinant_JJ inbred_JJ strain_NN derived_VBN by_IN
        inbreeding_VBG offspring_NN from_IN an_DT intercross_NNS between_IN mice_NNS of_IN the_DT
        D_NNP 2_CD and_CC AKR_NNP /_NN J_NNP strains_NNS [_NN 17_CD ]_NN ._. AKXD_NNP 28_CD mice_NNS ,_, therefore_RB ,_, have_VBP a_DT
        genetic_JJ background_NN that_WDT is_VBZ a_DT mix_NN of_IN the_DT D_NNP 2_CD (_( glaucomatous_JJ )_)
        and_CC AKR_NNP /_NN J_NNP (_( normal_JJ eyes_NNS with_IN no_DT obvious_JJ disease_NN )_) genomes_NNS ._.
        Due_JJ to_TO extensive_JJ inbreeding_VBG ,_, all_DT AKXD_NNP 28_CD mice_NNS are_VBP
        genetically_RB identical_JJ except_IN for_IN the_DT sex_NN chromosome_NN
        difference_NN between_IN males_NNS and_CC females_NNS ._. This_DT genetic_JJ
        uniformity_NN is_VBZ important_JJ for_IN the_DT analysis_NN of_IN complex_JJ
        diseases_NNS because_IN it_PRP allows_VBZ repeated_VBN and_CC therefore_RB accurate_JJ
        assessment_NN of_IN phenotypes_NNS associated_VBN with_IN the_DT AKXD_NNP 28_CD mix_NN of_IN
        D_NNP 2_CD and_CC AKR_NNP /_NN J_NNP genomes_NNS ._. AKXD_NNP 28_CD mice_NNS inherited_VBD the_DT glaucoma_NN
        causing_VBG 
        ipd_NN and_CC 
        isa_NN alleles_NNS from_IN strain_NN D_NNP 2_CD ._. This_DT is_VBZ
        evident_JJ by_IN their_PRP$ brown_JJ coat_NN color_NN and_CC the_DT inheritance_NN of_IN D_NNP 2_CD
        derived_VBN microsatellite_NN markers_NNS flanking_VBG these_DT loci_NN [_NN 18_CD ,_,
        19_CD ,_, 20_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD ]_NN ._. To_TO further_VB assess_VB the_DT phenotypic_JJ
        consequences_NNS of_IN 
        ipd_NN and_CC 
        isa_NN and_CC whether_IN their_PRP$ effect_NN is_VBZ
        modified_VBN in_IN the_DT AKXD_NNP 28_CD genetic_JJ background_NN ,_, we_PRP performed_VBD a_DT
        detailed_VBN characterization_NN of_IN the_DT ocular_NN phenotype_NN in_IN AKXD_NNP 28_CD
        mice_NNS ._.
        As_IN demonstrated_VBN here_RB ,_, AKXD_NNP 28_CD mice_NNS develop_VBP an_DT age_NN related_VBD
        glaucoma_NN involving_VBG increased_VBN IOP_NNP and_CC optic_JJ nerve_NN damage_NN ,_,
        and_CC they_PRP are_VBP a_DT useful_JJ tool_NN for_IN glaucoma_NN research_NN ._. The_DT
        AKXD_NNP 28_CD disease_NN has_VBZ a_DT number_NN of_IN similarities_NNS to_TO that_DT
        observed_VBD in_IN D_NNP 2_CD mice_NNS ._. Importantly_NNP ,_, however_RB ,_, two_CD major_JJ
        differences_NNS exist_VBP between_IN the_DT disease_NN in_IN AKXD_NNP 28_CD and_CC D_NNP 2_CD mice_NNS
        housed_VBN in_IN the_DT same_JJ environment_NN ._. First_LS ,_, AKXD_NNP 28_CD mice_NNS do_VBP not_RB
        develop_VB the_DT IPD_NNP phenotype_NN ._. The_DT absence_NN of_IN the_DT IPD_NNP phenotype_NN
        is_VBZ surprising_JJ considering_VBG AKXD_NNP 28_CD 's_POS inheritance_NN of_IN the_DT D_NNP 2_CD
        chromosomal_NN region_NN containing_VBG the_DT 
        ipd_NN gene_NN ,_, and_CC likely_JJ results_NNS from_IN
        genetic_JJ differences_NNS between_IN these_DT strains_NNS ._. Understanding_NNP
        these_DT differences_NNS will_MD be_VB important_JJ for_IN understanding_NN
        pigment_NN dispersion_NN ,_, a_DT common_JJ cause_NN of_IN human_JJ glaucoma_NN ._.
        Second_JJ ,_, although_IN D_NNP 2_CD and_CC AKXD_NNP 28_CD strains_NNS demonstrate_VBP similar_JJ
        magnitudes_NNS of_IN IOP_NNP ,_, AKXD_NNP 28_CD mice_NNS develop_VBP more_RBR severe_JJ and_CC more_RBR
        extensive_JJ retinal_JJ damage_NN and_CC are_VBP more_RBR prone_JJ to_TO optic_JJ nerve_NN
        head_NN excavation_NN than_IN D_NNP 2_CD mice_NNS ._. This_DT suggests_VBZ that_WDT compared_VBD
        to_TO D_NNP 2_CD mice_NNS ,_, AKXD_NNP 28_CD mice_NNS have_VBP an_DT increased_VBN genetic_JJ
        susceptibility_NN to_TO pressure-induced_JJ damage_NN ._. Identifying_NNP the_DT
        genes_NNS that_WDT differ_VBP between_IN AKXD_NNP 28_CD and_CC D_NNP 2_CD mice_NNS and_CC that_WDT
        modify_VB the_DT progression_NN and_CC severity_NN of_IN pressure-induced_JJ
        retinal_JJ cell_NN death_NN will_MD be_VB important_JJ for_IN understanding_NN
        mechanisms_NNS killing_VBG cells_NNS in_IN glaucoma_NN and_CC may_MD ultimately_RB
        lead_VB to_TO improved_VBN patient_NN care_NN ._.
      
      
        Results_NNS
        
          AKXD_NNP 28_CD develop_VB ISA_NNP but_CC not_RB IPD_NNP
          Consistent_NNP with_IN the_DT inheritance_NN of_IN 
          isa_NN from_IN strain_NN D_NNP 2_CD ,_, the_DT iris_NNS stroma_NN
          of_IN AKXD_NNP 28_CD mice_NNS atrophied_JJ with_IN age_NN (_( Figure_NN 1_LS )_) ._. The_DT first_JJ
          signs_NNS of_IN ISA_NNP were_VBD small_JJ focal_JJ peripheral_JJ
          transillumination_NN defects_NNS at_IN 6_CD to_TO 8_CD months_NNS of_IN age_NN ._. Iris_NNP
          stromal_NN atrophy_NN was_VBD histologically_RB evident_JJ in_IN most_JJS eyes_NNS
          by_IN 15_CD months_NNS ._. ISA_NNP became_VBD progressively_RB more_RBR severe_JJ ,_,
          profoundly_RB affecting_VBG all_DT eyes_NNS by_IN 23_CD months_NNS (_( Table_NNP 1_CD ,_,
          Figure_NN 1_LS )_) ._.
          AKXD_NNP 28_CD mice_NNS contain_VBP D_NNP 2_CD derived_VBN alleles_NNS for_IN markers_NNS 
          Mtv_NNP 23_CD and_CC 
          D_NNP 6_CD Nds_NNP 3_CD which_WDT are_VBP located_VBN
          approximately_RB 9_CD ._. 5_CD cM_NN proximal_NN and_CC 5_CD cM_NN distal_NN to_TO 
          ipd_NN ,_, respectively_RB [_NN 12_CD ,_, 22_CD ,_, 23_CD ]_NN ._.
          Additionally_RB ,_, AKXD-_NNP 28_CD /_NN Ty_NNP mice_NNS contain_VBP D_NNP 2_CD derived_VBN
          microsatellite_NN markers_NNS for_IN 
          D_NNP 6_CD Mit_NNP 207_CD ,_, 
          D_NNP 6_CD Mit_NNP 33_CD ,_, and_CC 
          D_NNP 6_CD Mit_NNP 93_CD which_WDT subdivide_NN this_DT region_NN
          and_CC are_VBP tightly_RB linked_VBN to_TO 
          ipd_NN (_( data_NNS not_RB shown_VBN )_) ._. Despite_IN
          inheritance_NN of_IN the_DT 
          ipd_NN chromosomal_NN segment_NN from_IN strain_NN
          D_NNP 2_CD ,_, both_DT histological_JJ and_CC clinical_JJ analysis_NN of_IN AKXD_NNP 28_CD
          irides_NNS and_CC anterior_NN chambers_NNS failed_VBD to_TO detect_VB the_DT
          presence_NN of_IN IPD_NNP at_IN all_DT ages_NNS examined_VBD ._. IPD_NNP is_VBZ
          characterized_VBN by_IN deterioration_NN of_IN the_DT iris_NNS pigment_NN
          epithelium_NN with_IN accumulation_NN of_IN dispersed_VBD pigment_NN and_CC
          pigment_NN filled_VBD cells_NNS in_IN the_DT anterior_NN chamber_NN and_CC on_IN the_DT
          front_NN of_IN the_DT iris_NNS and_CC lens_NN [_NN 12_CD ]_NN (_( Figure_NN 1_CD e_SYM )_) ._. No_DT pigment_NN
          dispersion_NN or_CC accumulation_NN was_VBD observed_VBN in_IN AKXD_NNP 28_CD eyes_NNS
          (_( Figure_NN 1_CD a_DT ,_, b_SYM ,_, c_SYM )_) ,_, and_CC the_DT iris_NNS pigment_NN epithelium_NN remained_VBD
          remarkably_RB intact_JJ considering_VBG the_DT severe_JJ iris_NNS stromal_NN
          atrophy_NN (_( Figure_NN 1_CD h_NN )_) ._. The_DT overall_JJ condition_NN of_IN the_DT iris_NNS in_IN
          old_JJ AKXD_NNP 28_CD versus_CC old_JJ D_NNP 2_CD mice_NNS also_RB indicated_VBD the_DT lack_NN of_IN
          the_DT IPD_NNP phenotype_NN in_IN AKXD_NNP 28_CD ._. D_NNP 2_CD mice_NNS succumb_NN to_TO both_DT ISA_NNP
          and_CC IPD_NNP ,_, and_CC develop_VB iris_NNS atrophy_NN that_WDT progresses_VBZ to_TO the_DT
          point_NN of_IN transparency_NN over_IN most_JJS of_IN the_DT iris_NNS (_( Figure_NN 1_CD f_SYM )_) ._.
          The_DT irides_NNS of_IN AKXD_NNP 28_CD eyes_NNS maintain_VBP substantially_RB greater_JJR
          tissue_NN integrity_NN and_CC pigmentation_NN (_( compare_VB Figure_NN 1_CD c_SYM to_TO
          fand_NN 1_CD h_NN to_TO i_NNP )_) ._.
        
        
          Anterior_NNP synechiae_NN and_CC increased_VBN IOP_NNP in_IN
          AKXD_NNP 28_CD
          The_DT ISA_NNP phenotype_NN in_IN D_NNP 2_CD mice_NNS involves_VBZ deterioration_NN of_IN
          the_DT iris_NNS stroma_NN and_CC release_NN of_IN cellular_JJ debris_NN into_IN the_DT
          anterior_NN chamber_NN ._. This_DT leads_VBZ to_TO the_DT formation_NN of_IN
          adhesions_NNS (_( anterior_NN synechiae_NN )_) that_WDT block_VBP aqueous_JJ humor_NN
          access_NN to_TO its_PRP$ drainage_NN pathways_NNS including_VBG the_DT trabecular_NN
          meshwork_NN and_CC Schlemm_NNP 's_POS canal_NN in_IN the_DT iridocorneal_NN angle_NN [_NN
          11_CD ,_, 12_CD ]_NN ._. AKXD_NNP 28_CD mice_NNS similarly_RB develop_VBP iris_NNS stromal_NN
          atrophy_NN ,_, anterior_NN synechiae_NN ,_, and_CC IOP_NNP elevation_NN (_( Figure_NN
          2_LS )_) ._. In_IN AKXD_NNP 28_CD ,_, the_DT synechiae_NN were_VBD first_JJ evident_JJ at_IN 9_CD
          months_NNS ,_, and_CC were_VBD extensive_JJ in_IN most_JJS eyes_NNS by_IN 15_CD to_TO 22_CD
          months_NNS of_IN age_NN (_( Table_NNP 1_LS )_) ._.
          To_TO assess_VB the_DT functional_JJ relationship_NN between_IN these_DT
          morphological_JJ abnormalities_NNS and_CC aqueous_JJ drainage_NN ,_, we_PRP
          determined_VBD the_DT IOPs_NNP of_IN AKXD_NNP 28_CD mice_NNS at_IN various_JJ ages_NNS
          (_( Figure_NN 2_LS )_) ._. IOP_NNP increased_VBN significantly_RB with_IN age_NN
          (_( P_NN =_SYM 0_CD ._. 0001_CD )_) and_CC pressure_NN elevation_NN followed_VBD a_DT time_NN course_NN
          consistent_JJ with_IN obstruction_NN of_IN aqueous_JJ humor_NN drainage_NN by_IN
          extensive_JJ anterior_NN synechiae_NN formation_NN ._. Although_IN there_EX
          were_VBD no_DT obvious_JJ histologic_JJ differences_NNS between_IN males_NNS and_CC
          females_NNS ,_, gender_NN had_VBD a_DT significant_JJ effect_NN on_IN the_DT timing_NN of_IN
          IOP_NNP elevation_NN (_( P_NN =_SYM 0_CD ._. 008_CD )_) ._. Among_IN females_NNS ,_, the_DT mean_NN IOP_NNP
          increased_VBD from_IN 12_CD ._. 9_CD ±_NN 0_CD ._. 3_CD mmHg_NN at_IN 7_CD to_TO 10_CD months_NNS (_( when_WRB
          synechiae_NN were_VBD absent_JJ or_CC mild_JJ )_) to_TO a_DT peak_NN value_NN of_IN 19_CD ._. 8_CD ±_NN
          1_CD ._. 8_CD mmHg_NN at_IN 15_CD -_: 18_CD months_NNS (_( when_WRB synechiae_NN were_VBD often_RB
          moderate_JJ or_CC severe_JJ )_) ._. The_DT IOP_NNP of_IN males_NNS showed_VBD an_DT increase_NN
          from_IN 14_CD ._. 9_CD ±_NN 0_CD ._. 4_CD mmHg_NN at_IN 7_CD to_TO 10_CD months_NNS to_TO a_DT peak_NN of_IN 18_CD ._. 9_CD
          ±_NN 1_CD ._. 0_CD mmHg_NN at_IN 19_CD -_: 21_CD months_NNS ._. The_DT magnitudes_NNS of_IN IOP_NNP
          elevation_NN were_VBD similar_JJ to_TO those_DT in_IN D_NNP 2_CD mice_NNS [_NN 11_CD ]_NN ._.
          Vitreous_NNP glutamate_NN levels_NNS increase_VBP when_WRB IOP_NNP is_VBZ
          elevated_VBD in_IN various_JJ species_NNS and_CC this_DT increase_NN is_VBZ
          associated_VBN with_IN RGC_NNP death_NN [_NN 24_CD ,_, 25_CD ,_, 26_CD ]_NN ._. As_IN an_DT initial_JJ
          effort_NN to_TO assess_VB glutamate_NN levels_NNS in_IN AKXD_NNP 28_CD mice_NNS ,_,
          vitreous_JJ was_VBD collected_VBN from_IN mice_NNS of_IN different_JJ ages_NNS and_CC
          subjected_VBN to_TO amino_JJ acid_NN analysis_NN ._. In_IN this_DT study_NN ,_, we_PRP
          analyzed_VBD two_CD pools_NNS of_IN samples_NNS from_IN 14_CD month_NN old_JJ mice_NNS and_CC
          two_CD pools_NNS of_IN samples_NNS from_IN 16_CD month_NN old_JJ mice_NNS ._. Pooling_NNP was_VBD
          necessary_JJ due_NN to_TO the_DT small_JJ volume_NN of_IN vitreous_JJ collected_VBN ,_,
          and_CC each_DT pool_NN consisted_VBD of_IN 2_CD to_TO 4_CD eyes_NNS (_( see_VB Materials_NNPS and_CC
          methods_NNS )_) ._. In_IN this_DT study_NN ,_, vitreous_JJ glutamate_NN levels_NNS were_VBD
          13_CD ._. 2_LS ±_NN 1_CD ._. 7_CD μM_NN in_IN 14_CD month_NN old_JJ mice_NNS (_( when_WRB IOP_NNP is_VBZ generally_RB
          normal_JJ )_) and_CC 29_CD ._. 2_LS ±_NN 4_CD ._. 7_CD μM_NN in_IN 16_CD month_NN old_JJ mice_NNS (_( when_WRB IOP_NNP
          is_VBZ often_RB elevated_VBD )_) ._.
        
        
          AKXD_NNP 28_CD develop_VB glaucomatous_JJ neuropathy_NN
          AKXD_NNP 28_CD mice_NNS develop_VBP several_JJ glaucomatous_JJ
          abnormalities_NNS ._. All_DT retinas_NNS had_VBD a_DT normal_JJ appearance_NN until_IN
          14_CD months_NNS when_WRB mild_JJ loss_NN of_IN retinal_JJ ganglion_NN cells_NNS was_VBD
          observed_VBN in_IN some_DT mice_NNS (_( Table_NNP 1_LS )_) ._. All_DT mice_NNS over_IN 18_CD months_NNS
          of_IN age_NN had_VBD severe_JJ ganglion_NN cell_NN loss_NN both_DT peripherally_RB
          and_CC close_RB to_TO the_DT optic_JJ nerve_NN (_( Figure_NN 3_CD ,_, Table_NNP 1_LS )_) ._.
          Atrophic_NNP excavation_NN of_IN the_DT optic_JJ nerve_NN head_NN was_VBD evident_JJ
          histologically_RB and_CC by_IN clinical_JJ fundus_JJ examination_NN in_IN old_JJ
          but_CC not_RB in_IN young_JJ mice_NNS (_( Figure_NN 3_CD ,_, Table_NNP 1_LS )_) ._. Fundus_NNP
          examination_NN was_VBD not_RB possible_JJ in_IN many_JJ old_JJ mice_NNS due_JJ to_TO
          corneal_JJ opacities_NNS and_CC cataracts_NNS ._.
          To_TO further_VB examine_VB the_DT progression_NN of_IN optic_JJ nerve_NN
          damage_NN ,_, optic_JJ nerve_NN cross_NN sections_NNS from_IN male_JJ and_CC female_JJ
          mice_NNS of_IN differing_VBG ages_NNS were_VBD analyzed_VBN (_( Figure_NN 4_LS )_) ._. Optic_NNP
          nerve_NN damage_NN was_VBD detected_VBN closely_RB following_VBG the_DT period_NN of_IN
          increased_VBN IOP_NNP ._. Moderate_NNP or_CC severe_JJ optic_JJ nerve_NN damage_NN was_VBD
          first_RB observed_VBD in_IN some_DT 17_CD month_NN old_JJ mice_NNS (_( 3_CD of_IN 12_CD )_) and_CC
          occurred_VBD in_IN almost_RB all_DT 19_CD -_: 20_CD month_NN old_JJ mice_NNS (_( 20_CD of_IN 22_CD )_) ._.
          Interestingly_RB ,_, optic_JJ nerve_NN damage_NN occurred_VBD earlier_JJR in_IN
          females_NNS than_IN in_IN males_NNS ._. Damage_NN was_VBD detectable_JJ in_IN female_JJ
          but_CC not_RB male_JJ nerves_NNS at_IN 17_CD months_NNS ._. By_IN 19_CD -_: 20_CD months_NNS all_DT
          female_JJ nerves_NNS were_VBD severely_RB affected_VBN ,_, whereas_IN ,_,
          approximately_RB half_NN of_IN the_DT male_JJ nerves_NNS were_VBD mildly_RB or_CC
          moderately_RB affected_VBN (_( P_NN =_SYM 0_CD ._. 02_CD ,_, Chi-square_NNP )_) (_( Figure_NN 4_CD d_SYM )_) ._.
        
        
          Retinal_NNP and_CC optic_JJ nerve_NN damage_NN is_VBZ more_RBR severe_JJ in_IN
          AKXD_NNP 28_CD than_IN D_NNP 2_CD
          Retinal_NNP damage_NN in_IN AKXD_NNP 28_CD eyes_NNS was_VBD more_RBR severe_JJ than_IN in_IN
          D_NNP 2_CD eyes_NNS (_( Figure_NN 3_CD ,_, Table_NNP 1_CD ,_, and_CC Ref_NNP ._. [_NN 11_CD ]_NN )_) ._. In_IN AKXD_NNP 28_CD
          mice_NNS ,_, IOP_NNP elevation_NN was_VBD first_RB noted_VBD in_IN a_DT few_JJ mice_NNS at_IN 11_CD
          months_NNS and_CC mild_JJ RGC_NNP depletion_NN (_( defined_VBN here_RB as_IN loss_NN of_IN
          cells_NNS in_IN the_DT RGC_NNP layer_NN )_) was_VBD initially_RB observed_VBN at_IN 14_CD
          months_NNS ._. By_IN 18_CD months_NNS RGC_NNP loss_NN was_VBD severe_JJ in_IN all_DT AKXD_NNP 28_CD
          eyes_NNS ._. By_IN contrast_NN ,_, D_NNP 2_CD mice_NNS exhibit_NN a_DT slower_JJR and_CC milder_JJR
          retinal_JJ disease_NN following_VBG increased_VBN IOP_NNP (_( compare_VB Figure_NN
          3_CD b_SYM ,_, c_SYM ,_, f_SYM )_) ._. In_IN D_NNP 2_CD mice_NNS ,_, IOP_NNP elevation_NN was_VBD first_RB observed_VBD in_IN
          some_DT mice_NNS at_IN 6_CD months_NNS ._. Mice_NNS at_IN 18_CD or_CC 19_CD months_NNS had_VBD no_RB
          more_JJR than_IN a_DT moderate_JJ loss_NN of_IN RGCs_NNP ,_, and_CC only_RB 1_CD of_IN 11_CD mice_NNS
          older_JJR than_IN 20_CD months_NNS had_VBD severe_JJ RGC_NNP loss_NN ._. Paralleling_NNP RGC_NNP
          loss_NN ,_, optic_JJ nerve_NN head_NN excavation_NN or_CC cupping_VBG was_VBD also_RB
          more_RBR severe_JJ and_CC more_RBR frequent_JJ (_( P_NN <_NN 0_CD ._. 0001_CD ,_, Chi-square_NNP )_)
          in_IN AKXD_NNP 28_CD than_IN D_NNP 2_CD mice_NNS ._. Optic_NNP nerve_NN excavation_NN was_VBD
          histologically_RB evident_JJ in_IN 27_CD of_IN 27_CD AKXD_NNP 28_CD mice_NNS that_WDT were_VBD
          18_CD months_NNS or_CC older_JJR and_CC was_VBD typically_RB severe_JJ (_( Table_NNP 1_LS )_) ._.
          The_DT severe_JJ atrophy_NN extended_VBN to_TO a_DT level_NN outside_IN of_IN the_DT
          inner_JJ nuclear_JJ layer_NN (_( INL_NNP )_) and_CC often_RB outside_IN the_DT choroid_NN
          (_( Figure_NN 3_CD e_SYM )_) ._. Optic_NNP nerve_NN excavation_NN occurred_VBD in_IN only_RB 11_CD
          of_IN 24_CD D_NNP 2_CD mice_NNS that_WDT were_VBD 18_CD months_NNS or_CC older_JJR ._. The_DT
          excavation_NN in_IN these_DT mice_NNS never_RB extended_VBN deeper_JJR than_IN the_DT
          INL_NNP and_CC was_VBD never_RB rated_VBN severe_JJ ._. Clinical_NNP fundus_JJ
          examinations_NNS agreed_VBD with_IN histological_JJ findings_NNS showing_VBG
          obvious_JJ ,_, severe_JJ optic_JJ nerve_NN damage_NN in_IN successfully_RB
          analyzed_VBD old_JJ AKXD_NNP 28_CD eyes_NNS but_CC not_RB in_IN D_NNP 2_CD eyes_NNS ._.
          In_IN addition_NN to_TO the_DT typical_JJ glaucomatous_JJ changes_NNS
          mentioned_VBN above_IN ,_, an_DT obvious_JJ loss_NN of_IN cells_NNS in_IN the_DT INL_NNP
          occurred_VBD in_IN almost_RB all_DT AKXD_NNP 28_CD mice_NNS 23_CD months_NNS old_JJ and_CC
          older_JJR (_( Table_NNP 1_CD ,_, Figure_NN 3_CD c_SYM )_) ._. In_IN some_DT AKXD_NNP 28_CD mice_NNS older_JJR
          than_IN 26_CD months_NNS ,_, the_DT disease_NN progressed_VBD to_TO affect_VB the_DT
          entire_JJ retina_NN with_IN substantial_JJ loss_NN of_IN both_DT INL_NNP cells_NNS and_CC
          photoreceptors_NNS ._. This_DT is_VBZ in_IN contrast_NN to_TO the_DT phenotype_NN in_IN
          D_NNP 2_CD mice_NNS ,_, in_IN which_WDT INL_NNP cell_NN loss_NN sometimes_RB occurred_VBD but_CC
          extensive_JJ damage_NN throughout_IN the_DT retina_NN was_VBD never_RB observed_VBN
          (_( Fig_NNP ._. 3_LS f_SYM )_) ._.
        
      
      
        Discussion_NNP
        
          An_DT AKR_NNP /_NN J_NNP modifier_NN (_( s_VBZ )_) likely_JJ suppresses_NNS IPD_NNP in_IN
          AKXD_NNP 28_CD
          A_DT significant_JJ difference_NN between_IN D_NNP 2_CD and_CC AKXD_NNP 28_CD mice_NNS is_VBZ
          the_DT lack_NN of_IN an_DT overt_JJ IPD_NNP phenotype_NN in_IN AKXD_NNP 28_CD ,_, despite_IN
          inheritance_NN of_IN the_DT 
          ipd_NN allele_NN from_IN D_NNP 2_CD ._. In_IN AKXD_NNP 28_CD ,_,
          there_EX is_VBZ no_DT obvious_JJ pigment_NN dispersion_NN ,_, the_DT iris_NNS pigment_NN
          epithelium_NN remains_VBZ remarkably_RB intact_JJ ,_, and_CC the_DT irides_NNS of_IN
          old_JJ mice_NNS remain_VBP pigmented_JJ ._. Evidence_NN that_IN the_DT 
          ipd_NN containing_VBG chromosomal_NN region_NN
          in_IN AKXD_NNP 28_CD is_VBZ derived_VBN from_IN D_NNP 2_CD includes_VBZ inheritance_NN of_IN D_NNP 2_CD
          alleles_NNS of_IN microsatellite_NN markers_NNS spanning_VBG an_DT
          approximately_RB 14_CD ._. 5_LS cM_NN chromosomal_NN region_NN surrounding_VBG the_DT 
          ipd_NN locus_JJ (_( delimited_JJ by_IN the_DT markers_NNS
          
          Mtv_NNP 23_CD and_CC 
          D_NNP 6_CD Nds_NNP 3_LS )_) [_NN 22_CD ,_, 23_CD ]_NN ._. Though_IN
          unlikely_JJ ,_, the_DT possibility_NN of_IN an_DT undetected_JJ
          recombinational_NN rearrangement_NN within_IN this_DT region_NN that_WDT
          placed_VBD an_DT AKR_NNP /_NN J_NNP allele_NN of_IN the_DT gene_NN that_IN causes_NNS IPD_NNP on_IN the_DT
          AKXD_NNP 28_CD chromosome_NN cannot_NN be_VB ruled_VBN out_RP ._. The_DT presence_NN in_IN
          AKXD_NNP 28_CD of_IN the_DT D_NNP 2_CD allele_NN of_IN 
          D_NNP 6_CD Mit_NNP 33_CD ,_, which_WDT maps_NNS to_TO the_DT same_JJ
          position_NN as_IN 
          ipd_NN (_( 25_CD ._. 5_LS cM_NN )_) ,_, argues_VBZ against_IN such_JJ
          a_DT rearrangement_NN [_NN 12_CD ,_, 21_CD ]_NN ._. Other_JJ explanations_NNS for_IN the_DT
          absence_NN of_IN an_DT IPD_NNP phenotype_NN in_IN AKXD_NNP 28_CD include_VBP :_:
          inheritance_NN of_IN an_DT AKR_NNP /_NN J_NNP modifier_NN gene_NN (_( s_VBZ )_) that_IN suppresses_NNS
          the_DT IPD_NNP phenotype_NN ,_, a_DT spontaneous_JJ reversion_NN of_IN the_DT 
          ipd_NN mutation_NN in_IN AKXD_NNP 28_CD mice_NNS ,_, or_CC the_DT
          spontaneous_JJ occurrence_NN and_CC fixation_NN of_IN the_DT 
          ipd_NN mutation_NN in_IN strain_NN D_NNP 2_CD after_IN the_DT
          derivation_NN of_IN the_DT AKXD_NNP 28_CD strain_NN ._. Inheritance_NNP of_IN an_DT AKR_NNP /_NN J_NNP
          modifier_NN seems_VBZ the_DT most_RBS likely_JJ explanation_NN but_CC
          elucidation_NN of_IN the_DT molecular_JJ nature_NN of_IN the_DT 
          ipd_NN mutation_NN or_CC the_DT mapping_NN of_IN a_DT
          modifier_NN gene_NN (_( s_VBZ )_) is_VBZ necessary_JJ to_TO distinguish_VB among_IN the_DT
          possibilities_NNS ._.
        
        
          IOP_NNP elevation_NN occurs_VBZ earlier_JJR in_IN females_NNS
          Female_NNP AKXD_NNP 28_CD mice_NNS exhibit_NN increased_VBD IOP_NNP earlier_JJR than_IN
          males_NNS ._. Nerve_NNP damage_NN was_VBD also_RB first_RB observed_VBD in_IN females_NNS ._.
          Our_PRP$ clinical_JJ and_CC histological_JJ studies_NNS identified_VBD no_DT
          obvious_JJ gender_NN differences_NNS in_IN anterior_NN segment_NN pathology_NN
          that_DT account_NN for_IN this_DT ._. It_PRP must_MD be_VB remembered_VBN ,_, however_RB ,_,
          that_IN our_PRP$ histological_JJ analysis_NN accounts_NNS for_IN a_DT small_JJ
          portion_NN of_IN the_DT eye_NN and_CC so_RB differences_NNS in_IN the_DT prevalence_NN
          or_CC severity_NN of_IN anterior_NN synechiae_NN may_MD have_VB been_VBN missed_VBN ._.
          Further_RB experiments_NNS including_VBG more_RBR detailed_JJ analysis_NN of_IN
          the_DT aqueous_JJ drainage_NN system_NN are_VBP necessary_JJ to_TO understand_VB
          why_WRB IOP_NNP elevation_NN occurs_VBZ earlier_JJR in_IN females_NNS than_IN males_NNS ._.
          Interestingly_RB ,_, D_NNP 2_CD females_NNS also_RB exhibit_NN increased_VBD IOP_NNP
          prior_RB to_TO males_NNS [_NN 11_CD ]_NN ._. Sex-specific_NNP differences_NNS in_IN human_JJ
          glaucoma_NN susceptibility_NN have_VBP been_VBN reported_VBN in_IN some_DT ,_, but_CC
          not_RB all_DT human_JJ studies_NNS [_NN 33_CD ,_, 34_CD ,_, 35_CD ,_, 36_CD ,_, 37_CD ]_NN ._. In_IN general_JJ ,_,
          sex-specific_JJ differences_NNS in_IN human_JJ glaucoma_NN may_MD be_VB
          difficult_JJ to_TO identify_VB or_CC interpret_VB because_IN of_IN genetic_JJ
          differences_NNS and_CC uncontrolled_JJ environmental_JJ factors_NNS
          between_IN patients_NNS that_WDT may_MD alter_VB the_DT phenotype_NN ._. Since_IN they_PRP
          are_VBP inbred_JJ and_CC environment_NN can_MD be_VB highly_RB controlled_VBN ,_,
          AKXD_NNP 28_CD mice_NNS provide_VBP an_DT experimental_JJ resource_NN for_IN
          examining_VBG the_DT biological_JJ significance_NN of_IN gender_NN for_IN
          susceptibility_NN to_TO events_NNS that_WDT elevate_NN IOP_NNP ._.
        
        
          AKXD_NNP 28_CD and_CC D_NNP 2_CD have_VBP different_JJ susceptibilities_NNS to_TO
          pressure-induced_JJ damage_NN
          Overall_RB ,_, the_DT progression_NN of_IN optic_JJ nerve_NN and_CC retinal_JJ
          disease_NN in_IN AKXD_NNP 28_CD mice_NNS supports_VBZ a_DT pressure-induced_JJ
          etiology_NN ._. Optic_NNP nerve_NN and_CC retinal_JJ damage_NN were_VBD only_RB
          observed_VBN at_IN ages_NNS after_IN high_JJ IOP_NNP was_VBD detected_VBN ._. Following_VBG
          the_DT period_NN of_IN increased_VBN IOP_NNP ,_, the_DT retinas_NNS and_CC optic_JJ nerves_NNS
          of_IN aged_VBN AKXD_NNP 28_CD mice_NNS undergo_VBP substantially_RB greater_JJR damage_NN
          than_IN those_DT of_IN D_NNP 2_CD mice_NNS ._. The_DT damage_NN also_RB occurs_VBZ more_RBR
          rapidly_RB after_IN IOP_NNP elevation_NN is_VBZ first_RB detected_VBN in_IN AKXD_NNP 28_CD
          compared_VBN to_TO D_NNP 2_CD ._. Strikingly_NNP ,_, all_DT old_JJ AKXD_NNP 28_CD mice_NNS have_VBP
          severe_JJ retinal_JJ ganglion_NN cell_NN loss_NN typically_RB associated_VBN
          with_IN severe_JJ optic_JJ nerve_NN excavation_NN ,_, whereas_IN ,_, few_JJ old_JJ D_NNP 2_CD
          mice_NNS have_VBP severe_JJ RGC_NNP loss_NN and_CC optic_JJ nerve_NN excavation_NN is_VBZ
          rarely_RB ,_, if_IN ever_RB severe_JJ (_( defined_VBN here_RB as_IN extending_VBG to_TO a_DT
          level_NN out_IN side_NN of_IN the_DT inner_JJ nuclear_JJ layer_NN )_) ._. Additionally_RB ,_,
          following_VBG initial_JJ RGC_NNP loss_NN ,_, most_JJS AKXD_NNP 28_CD eyes_NNS exhibit_NN
          thinning_VBG of_IN the_DT inner_JJ nuclear_JJ layer_NN ,_, and_CC some_DT mice_NNS older_JJR
          than_IN 26_CD months_NNS show_VBP severe_JJ depletion_NN of_IN all_DT retinal_JJ
          layers_NNS ._. Such_JJ severe_JJ and_CC extensive_JJ retinal_JJ damage_NN never_RB
          occurs_VBZ in_IN strain_NN D_NNP 2_CD ._. The_DT RGC_NNP layer_NN is_VBZ primarily_RB affected_VBN
          in_IN most_JJS old_JJ D_NNP 2_CD mice_NNS with_IN the_DT occurrence_NN of_IN mild_JJ inner_JJ
          nuclear_JJ layer_NN cell_NN loss_NN and_CC possibly_RB ,_, very_RB mild_JJ
          photoreceptor_NN loss_NN in_IN only_RB some_DT mice_NNS ._. In_IN our_PRP$ studies_NNS ,_, the_DT
          occurrence_NN of_IN outer_JJ retinal_JJ damage_NN was_VBD only_RB observed_VBN in_IN
          old_JJ AKXD_NNP 28_CD eyes_NNS with_IN late_JJ stage_NN disease_NN ,_, typically_RB
          several_JJ months_NNS after_IN signs_NNS of_IN glaucoma_NN were_VBD evident_JJ ,_, and_CC
          was_VBD a_DT late_JJ consequence_NN of_IN disease_NN progression_NN ._. Although_IN
          RGCs_NNP are_VBP generally_RB accepted_VBN to_TO be_VB the_DT major_JJ cell_NN type_NN
          affected_VBN in_IN human_JJ glaucoma_NN ,_, and_CC to_TO our_PRP$ knowledge_NN INL_NNP and_CC
          photoreceptor_NN cell_NN loss_NN similar_JJ to_TO that_DT in_IN AKXD_NNP 28_CD has_VBZ not_RB
          been_VBN reported_VBN ,_, there_EX is_VBZ evidence_NN for_IN INL_NNP and_CC
          photoreceptor_NN cell_NN involvement_NN in_IN some_DT human_NN and_CC monkey_NN
          cases_NNS [_NN 38_CD ,_, 39_CD ,_, 40_CD ,_, 41_CD ,_, 42_CD ,_, 43_CD ]_NN ._.
          Both_DT AKXD_NNP 28_CD and_CC D_NNP 2_CD have_VBP similar_JJ magnitudes_NNS and_CC
          durations_NNS of_IN increased_VBN IOP_NNP ,_, with_IN the_DT duration_NN appearing_VBG
          to_TO last_VB a_DT little_JJ longer_RBR in_IN the_DT more_RBR mildly_RB affected_VBN D_NNP 2_CD
          strain_NN ._. The_DT IOP_NNP distribution_NN of_IN D_NNP 2_CD females_NNS is_VBZ
          significantly_RB elevated_VBD from_IN 8_CD to_TO 12_CD months_NNS of_IN age_NN and_CC
          AKXD_NNP 28_CD females_NNS from_IN 15_CD to_TO 18_CD months_NNS ._. Although_IN the_DT
          duration_NN of_IN IOP_NNP elevation_NN in_IN AKXD_NNP 28_CD males_NNS is_VBZ not_RB yet_RB
          characterized_VBN ,_, female_JJ AKXD_NNP 28_CD mice_NNS are_VBP affected_VBN more_RBR
          severely_RB than_IN D_NNP 2_CD mice_NNS of_IN either_DT sex_NN ._. Thus_RB ,_, the_DT duration_NN
          and_CC magnitude_NN of_IN IOP_NNP elevation_NN does_VBZ not_RB seem_VB to_TO underlie_VB
          the_DT more_RBR severe_JJ damage_NN in_IN AKXD_NNP 28_CD ._. The_DT greater_JJR severity_NN
          and_CC speed_NN of_IN damage_NN following_VBG IOP_NNP elevation_NN in_IN AKXD_NNP 28_CD
          compared_VBN to_TO D_NNP 2_CD mice_NNS housed_VBN in_IN the_DT same_JJ environment_NN ,_,
          therefore_RB ,_, suggests_VBZ that_IN AKXD_NNP 28_CD is_VBZ more_RBR susceptible_JJ to_TO
          pressure-induced_JJ cell_NN death_NN ._. Future_JJ experiments_NNS involving_VBG
          D_NNP 2_CD and_CC AKXD_NNP 28_CD may_MD allow_VB identification_NN of_IN genes_NNS (_( s_VBZ )_) that_WDT
          modulate_VBP susceptibility_NN to_TO pressure-induced_JJ damage_NN and_CC
          that_DT may_MD be_VB relevant_JJ for_IN human_JJ glaucoma_NN ._. Identification_NNP
          of_IN genes_NNS that_WDT modify_VB pressure-induced_JJ cell_NN death_NN and_CC
          characterization_NN of_IN the_DT mechanisms_NNS by_IN which_WDT they_PRP act_VBP will_MD
          broaden_VB the_DT knowledge_NN base_NN from_IN which_WDT informed_VBD decisions_NNS
          regarding_VBG patient_NN counseling_NN ,_, screening_NN ,_, and_CC treatment_NN
          are_VBP made_VBN ._.
        
        
          Systems_NNS that_WDT may_MD alter_VB susceptibility_NN to_TO
          pressure-induced_JJ damage_NN
          Known_VBN characteristics_NNS of_IN the_DT AKR_NNP /_NN J_NNP and_CC D_NNP 2_CD strains_NNS
          offer_VBP few_JJ clues_NNS to_TO AKXD_NNP 28_CD 's_POS increased_VBN susceptibility_NN to_TO
          pressure-induced_JJ damage_NN and_CC all_DT explanatory_JJ attempts_NNS are_VBP
          speculative_JJ ._. The_DT propensity_NN for_IN handling-induced_JJ hyphema_NN
          and_CC subconjunctival_NN hemorrhage_NN that_IN we_PRP observe_VBP (_( see_VB Table_NNP
          1_LS )_) in_IN AKXD_NNP 28_CD may_MD indicate_VB vascular_NN abnormalities_NNS with_IN
          relatively_RB weak_JJ blood_NN vessels_NNS and_CC capillary_JJ beds_NNS ._.
          Weakened_NNP capillaries_NNS may_MD not_RB function_VB optimally_RB in_IN the_DT
          face_NN of_IN elevated_VBD IOP_NNP resulting_VBG in_IN some_DT degree_NN of_IN retinal_JJ
          ischemia_NN that_WDT exacerbates_VBZ retinal_JJ cell_NN death_NN ._. Retinal_NNP
          ischemia_NN is_VBZ known_VBN to_TO affect_VB cell_NN viability_NN in_IN the_DT INL_NNP and_CC
          photoreceptor_NN layers_NNS [_NN 44_CD ]_NN ._. Ischemia_NNP would_MD likely_RB invoke_VB
          glutamate_NN induced_VBD neurotoxicity_NN [_NN 45_CD ,_, 46_CD ]_NN ._.
          Equally_RB plausible_JJ is_VBZ the_DT possibility_NN of_IN differing_VBG
          neurotoxic_JJ responses_NNS to_TO glutamate_NN or_CC differences_NNS in_IN the_DT
          ability_NN of_IN AKXD_NNP 28_CD and_CC D_NNP 2_CD mice_NNS to_TO buffer_VB glutamate_NN levels_NNS
          in_IN the_DT face_NN of_IN high_JJ IOP_NNP ._. Acting_NN through_IN
          N-_NNP methyl-_NN D-_NNP aspartate_NN receptors_NNS ,_, glutamate_NN is_VBZ believed_VBN to_TO
          be_VB a_DT potent_JJ initiator_NN of_IN RGC_NNP neurotoxicity_NN [_NN 26_CD ]_NN and_CC ,_, as_IN
          described_VBN here_RB ,_, the_DT vitreous_JJ of_IN at_IN least_JJS some_DT AKXD_NNP 28_CD mice_NNS
          contains_VBZ elevated_VBD glutamate_NN concentrations_NNS when_WRB IOP_NNP is_VBZ
          elevated_VBD ._. Studies_NNS with_IN human_JJ eyes_NNS have_VBP previously_RB
          reported_VBN an_DT increase_NN in_IN vitreous_JJ glutamate_NN levels_NNS from_IN
          approximately_RB 10_CD μM_NN in_IN non-glaucomatous_JJ eyes_NNS to_TO 23_CD μM_NN in_IN
          glaucomatous_JJ eyes_NNS [_NN 24_CD ]_NN ._. Also_RB ,_, chronic_JJ elevation_NN of_IN rat_NN
          vitreous_JJ glutamate_NN levels_NNS from_IN approximately_RB 5_CD -_: 12_CD μM_NN to_TO
          26_CD -_: 34_CD μM_NN has_VBZ previously_RB been_VBN shown_VBN to_TO be_VB toxic_JJ to_TO RGCs_NNP [_NN
          25_CD ,_, 26_CD ]_NN ._. The_DT higher_JJR vitreous_JJ glutamate_NN concentrations_NNS we_PRP
          observed_VBD in_IN 16_CD month_NN old_JJ (_( 29_CD ._. 2_LS ±_NN 4_CD ._. 7_CD μM_NN )_) compared_VBN to_TO 14_CD
          month_NN old_JJ (_( 13_CD ._. 2_LS ±_NN 1_CD ._. 7_CD μM_NN )_) AKXD_NNP 28_CD mice_NNS would_MD ,_, therefore_RB ,_,
          be_VB expected_VBN to_TO damage_VB the_DT retina_NN ._. Although_IN these_DT findings_NNS
          are_VBP promising_JJ and_CC implicate_VB glutamate_NN in_IN retinal_JJ
          neurotoxicity_NN in_IN AKXD_NNP 28_CD mice_NNS ,_, further_JJ experiments_NNS are_VBP
          needed_VBN to_TO completely_RB characterize_VB vitreous_JJ glutamate_NN
          levels_NNS and_CC their_PRP$ relationship_NN to_TO IOP_NNP and_CC glaucoma_NN in_IN this_DT
          strain_NN ._.
          Molecules_NNP involved_VBD in_IN glutamate_NN metabolism_NN ,_, signaling_VBG ,_,
          or_CC buffering_VBG are_VBP interesting_JJ candidates_NNS to_TO alter_VB
          susceptibility_NN to_TO retinal_JJ cell_NN death_NN ._. An_DT intriguing_JJ
          possibility_NN is_VBZ that_IN AKXD_NNP 28_CD and_CC D_NNP 2_CD mice_NNS have_VBP differing_VBG
          responses_NNS to_TO platelet-activating_JJ factor_NN (_( PAF_NNP )_) ._. PAF_NNP is_VBZ a_DT
          biologically_RB active_JJ phospholipid_NN mediator_NN ._. PAF_NNP acts_NNS by_IN
          binding_VBG to_TO a_DT unique_JJ G_NNP protein_NN coupled_VBN transmembrane_NN
          receptor_NN ,_, PTAFR_NNP ,_, that_WDT is_VBZ broadly_RB expressed_VBN in_IN the_DT eye_NN [_NN
          47_CD ]_NN ._. Relevant_NNP activities_NNS of_IN PAF_NNP include_VBP promoting_VBG ocular_NN
          hypertension_NN and_CC enhancing_VBG neural_NN glutamate_NN release_NN [_NN 48_CD ,_,
          49_CD ,_, 50_CD ]_NN ._. Interestingly_RB ,_, AKR_NNP /_NN J_NNP airways_NNS have_VBP a_DT strain_NN
          specific_JJ hyper-responsive_JJ reaction_NN to_TO intravenously_RB
          injected_VBN PAF_NNP [_NN 51_CD ]_NN ._. A_DT hyper-responsiveness_JJ of_IN AKXD_NNP 28_CD
          ocular_NN tissues_NNS to_TO PAF_NNP or_CC increased_VBN activity_NN of_IN the_DT PTAFR_NNP
          receptor_NN mediated_JJ signaling_VBG pathway_NN could_MD ,_, therefore_RB ,_,
          contribute_VB to_TO the_DT pronounced_VBN retinal_JJ damage_NN through_IN
          potentiating_VBG glutamate_NN neurotoxicity_NN ._.
        
      
      
        Conclusions_NNP
        We_PRP have_VBP documented_VBN the_DT development_NN of_IN a_DT disease_NN
        involving_VBG iris_NNS stromal_NN atrophy_NN and_CC glaucoma_NN in_IN aged_VBN AKXD_NNP 28_CD
        mice_NNS ._. These_DT results_NNS add_VBP to_TO our_PRP$ understanding_NN of_IN the_DT natural_JJ
        history_NN of_IN glaucoma_NN in_IN mice_NNS and_CC provide_VB a_DT new_JJ animal_NN model_NN
        for_IN studying_VBG glaucoma_NN involving_VBG increased_VBN IOP_NNP ._. Furthermore_RB ,_,
        careful_JJ phenotypic_JJ comparisons_NNS between_IN the_DT AKXD_NNP 28_CD and_CC D_NNP 2_CD
        strains_NNS suggests_VBZ that_IN the_DT AKXD_NNP 28_CD genome_NN contains_VBZ genetic_JJ
        modifiers_NNS that_WDT suppress_VB pigment_NN dispersion_NN and_CC increase_NN
        susceptibility_NN to_TO pressure-induced_JJ retinal_JJ damage_NN ._. These_DT
        results_NNS provide_VBP a_DT basis_NN for_IN future_JJ research_NN to_TO identify_VB
        glaucoma_NN modifier_NN genes_NNS and_CC to_TO dissect_NN the_DT molecular_JJ
        mechanisms_NNS by_IN which_WDT they_PRP act_VBP ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Animal_NNP husbandry_NN
          All_DT experiments_NNS were_VBD performed_VBN in_IN compliance_NN with_IN the_DT
          Association_NNP for_IN Research_NNP in_IN Vision_NNP and_CC Ophthalmology_NNP
          Statement_NNP for_IN Use_NN of_IN Animals_NNS in_IN Ophthalmic_NNP and_CC Vision_NNP
          Research_NNP ._. Mice_NNS were_VBD housed_VBN in_IN cages_NNS containing_VBG white_JJ pine_VBP
          bedding_NN and_CC covered_VBN with_IN polyester_NN filters_NNS ._. The_DT
          environment_NN was_VBD kept_VBN at_IN 21_CD °_NN C_NNP with_IN a_DT 14_CD -_: h_NN light_JJ :_: 10_CD -_: h_NN dark_JJ
          cycle_NN ._. Mice_NNS were_VBD fed_VBN NIH_NNP 31_CD (_( 6_CD %_NN fat_JJ )_) chow_NN 
          ad_NN libitum_NN ,_, and_CC their_PRP$ water_NN was_VBD
          acidified_VBN to_TO pH_NN 2_CD ._. 8_CD -_: 3_CD ._. 2_LS ._. All_DT mouse_NN strains_NNS used_VBN for_IN this_DT
          study_NN were_VBD routinely_RB screened_VBD for_IN select_VB pathogens_NNS by_IN The_DT
          Jackson_NNP Laboratory_NNP 's_POS routine_JJ surveillance_NN program_NN (_( see_VB
          http_NN :_: /_NN /_NN www_NN ._. jax_NN ._. org_NN for_IN specific_JJ pathogens_NNS )_) ._. The_DT mouse_NN
          strains_NNS used_VBN in_IN this_DT study_NN were_VBD DBA_NNP /_NN 2_CD J_NNP (_( D_NNP 2_LS )_) ,_, AKXD-_NNP 28_CD /_NN Ty_NNP
          (_( AKXD_NNP 28_CD )_) ,_, and_CC C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP (_( B_NNP 6_CD )_) ._. Cohorts_NNP of_IN D_NNP 2_CD and_CC AKXD_NNP 28_CD
          mice_NNS were_VBD housed_VBN in_IN the_DT same_JJ room_NN and_CC examined_VBD using_VBG
          identical_JJ protocols_NNS ._. The_DT majority_NN of_IN AKXD_NNP 28_CD mice_NNS were_VBD
          aged_VBN and_CC analyzed_VBN at_IN the_DT same_JJ time_NN as_IN groups_NNS of_IN D_NNP 2_CD mice_NNS
          reported_VBD in_IN a_DT previous_JJ study_NN [_NN 11_CD ]_NN ._. Some_DT AKXD_NNP 28_CD mice_NNS were_VBD
          subsequently_RB analyzed_VBN and_CC so_RB additional_JJ D_NNP 2_CD mice_NNS were_VBD aged_VBN
          and_CC analyzed_VBN at_IN the_DT same_JJ time_NN ._. The_DT disease_NN
          characteristics_NNS of_IN the_DT additional_JJ D_NNP 2_CD mice_NNS was_VBD the_DT same_JJ as_IN
          previously_RB described_VBD [_NN 11_CD ]_NN ._.
        
        
          Clinical_NNP examinations_NNS
          The_DT anterior_NN chambers_NNS of_IN male_JJ and_CC female_JJ AKXD_NNP 28_CD mice_NNS
          2_CD -_: 27_CD months_NNS of_IN age_NN were_VBD examined_VBN with_IN a_DT slit-lamp_JJ
          biomicroscope_NN (_( Haag-_NNP Streit_NNP ,_, Mason_NNP ,_, OH_NNP )_) ._. Observed_NNP clinical_JJ
          phenotypes_NNS were_VBD recorded_VBN at_IN the_DT time_NN of_IN examination_NN and_CC
          rated_VBN as_IN normal_JJ ,_, mild_JJ ,_, moderate_JJ ,_, or_CC severe_JJ based_VBN on_IN the_DT
          following_VBG criteria_NNS ._. Iris_NNP stromal_NN atrophy_NN (_( ISA_NNP )_) involves_VBZ a_DT
          loss_NN of_IN complex_JJ iris_NNS structure_NN due_JJ to_TO loss_NN of_IN iris_NNS
          stroma_NN ._. It_PRP was_VBD ranked_VBN as_IN mild_JJ (_( minor_JJ loss_NN of_IN iris_NNS
          complexity_NN )_) ,_, moderate_JJ (_( notable_JJ lack_NN of_IN iris_NNS complexity_NN
          and_CC focal_JJ thinning_VBG of_IN iris_NNS )_) ,_, or_CC severe_JJ (_( iris_NNS lacking_VBG
          complex_JJ morphology_NN and_CC is_VBZ thin_JJ ,_, frequently_RB with_IN focal_JJ
          full_JJ thickness_NN holes_NNS )_) ._. Transillumination_NNP (_( TRAN_NNP )_) refers_VBZ to_TO
          light_VB passed_VBN through_IN the_DT pupil_NN and_CC reflected_VBD off_RP the_DT back_NN
          of_IN the_DT eye_NN and_CC through_IN depigmented_JJ regions_NNS of_IN the_DT iris_NNS ._.
          TRAN_NNP was_VBD ranked_VBN as_IN peripheral_JJ (_( transillumination_NN limited_VBN
          to_TO peripheral_JJ iris_NNS )_) ,_, mild_JJ (_( individual_JJ specks_NNS of_IN
          transillumination_NN across_IN iris_NNS )_) ,_, moderate_JJ (_( individual_JJ
          specks_NNS and_CC focal_JJ areas_NNS of_IN mass_NN transillumination_NN )_) ,_, or_CC
          severe_JJ (_( majority_NN of_IN iris_NNS transilluminates_NNS easily_RB ,_,
          frequently_RB through_IN holes_NNS )_) ._. Dispersed_NNP pigment_NN (_( DP_NNP )_) refers_VBZ
          to_TO clinically_RB visible_JJ accumulations_NNS of_IN pigment_NN or_CC pigment_NN
          laden_JJ cells_NNS on_IN anterior_NN segment_NN surfaces_VBZ ,_, most_RBS frequently_RB
          observed_VBD on_IN the_DT lens_NN or_CC iris_NNS ._. Dispersed_NNP pigment_NN is_VBZ part_NN
          of_IN the_DT iris_NNS pigment_NN dispersion_NN phenotype_NN (_( IPD_NNP )_) that_WDT is_VBZ
          caused_VBN by_IN the_DT D_NNP 2_CD 
          ipd_NN allele_NN ._. Fundus_NNP examination_NN was_VBD
          performed_VBN with_IN pupils_NNS dilated_JJ by_IN a_DT drop_NN of_IN 1_CD %_NN atropine_NN
          sulfate_NN and_CC an_DT indirect_JJ ophthalmoscope_NN (_( American_NNP Optical_NNP ,_,
          Rochester_NNP ,_, NY_NNP )_) with_IN a_DT 60_CD -_: or_CC 90_CD -_: diopter_NN lens_NN ._. Our_PRP$ method_NN
          of_IN fundus_JJ photography_NN has_VBZ been_VBN previously_RB reported_VBN [_NN
          52_CD ]_NN ._.
        
        
          Ocular_NNP histologic_JJ processing_NN
          Enucleated_NNP eyes_NNS from_IN AKXD_NNP 28_CD mice_NNS 2_CD -_: 28_CD months_NNS old_JJ were_VBD
          fixed_VBN for_IN plastic_NN sectioning_VBG (_( 0_CD ._. 8_CD %_NN paraformaldehyde_NN and_CC
          1_CD ._. 2_CD %_NN glutaraldehyde_NN in_IN either_DT 0_CD ._. 1_CD M_NNP phosphate_NN buffer_NN ,_, pH_NN
          7_CD ._. 2_CD ,_, or_CC 0_CD ._. 1_CD M_NNP cacodylate_NN buffer_NN ,_, pH_NN 7_CD ._. 2_LS )_) or_CC for_IN paraffin_NN
          sectioning_VBG (_( 3_CD ._. 2_LS %_NN formaldehyde_NN ,_, 0_CD ._. 7_CD M_NNP acetic_JJ acid_NN ,_, 61_CD %_NN
          ethanol_NN )_) as_RB previously_RB described_VBD [_NN 11_CD ,_, 12_CD ]_NN ._. Serial_JJ
          sagittal_NN sections_NNS passing_VBG through_IN the_DT optic_JJ nerve_NN were_VBD
          collected_VBN ,_, stained_JJ with_IN hematoxylin_NN and_CC eosin_NN ,_, and_CC
          analyzed_VBD for_IN pathologic_JJ changes_NNS ._. To_TO control_VB for_IN variation_NN
          with_IN position_NN ,_, various_JJ phenotypes_NNS were_VBD only_RB assessed_VBN at_IN
          specific_JJ ocular_NN locations_NNS in_IN high_JJ quality_NN sections_NNS [_NN 11_CD ]_NN ._.
          Thus_RB ,_, the_DT number_NN of_IN eyes_NNS successfully_RB analyzed_VBD differs_VBZ
          with_IN the_DT phenotype_NN assessed_VBN ._. Optic_NNP nerve_NN cupping_VBG was_VBD only_RB
          judged_VBN from_IN sections_NNS containing_VBG central_JJ optic_JJ nerve_NN ._.
          Optic_NNP nerve_NN atrophy_NN ,_, retinal_JJ ganglion_NN cell_NN death_NN ,_, and_CC
          inner_JJ nuclear_JJ layer_NN cell_NN loss_NN were_VBD detectable_JJ in_IN central_JJ
          sections_NNS and_CC sections_NNS containing_VBG optic_JJ nerve_NN that_WDT were_VBD
          slightly_RB off_IN center_NN ._. Ocular_NNP lesions_NNS were_VBD rated_VBN as_IN normal_JJ ,_,
          mild_JJ ,_, moderate_JJ ,_, or_CC severe_JJ using_VBG previously_RB published_VBN
          criteria_NNS [_NN 11_CD ]_NN ._. Since_IN cell_NN counts_NNS were_VBD not_RB performed_VBN ,_,
          inner_JJ nuclear_JJ layer_NN cell_NN loss_NN was_VBD only_RB rated_VBN as_IN affected_VBN
          when_WRB obvious_JJ cell_NN loss_NN was_VBD evident_JJ (_( typically_RB at_IN least_JJS 2_CD
          to_TO 3_CD cell_NN layers_NNS missing_VBG )_) ._. One_CD D_NNP 2_CD eye_NN examined_VBD
          histologically_RB was_VBD excluded_VBN from_IN the_DT study_NN because_IN of_IN the_DT
          complicating_VBG presence_NN of_IN a_DT large_JJ corneal_JJ ulcer_NN
          accompanied_VBN by_IN severe_JJ intraocular_JJ inflammation_NN ;_: this_DT eye_NN
          had_VBD a_DT very_RB severe_JJ retinal_JJ phenotype_NN and_CC severe_JJ optic_JJ
          nerve_NN damage_NN ._.
        
        
          Optic_NNP nerve_NN histologic_JJ processing_NN
          Samples_NNP were_VBD processed_VBN as_RB previously_RB described_VBD [_NN 11_CD ]_NN ._.
          After_IN initial_JJ fixation_NN for_IN 24_CD -_: 48_CD hours_NNS ,_, optic_JJ nerves_NNS were_VBD
          carefully_RB dissected_VBN ,_, postfixed_JJ with_IN 1_CD %_NN osmium_NN tetroxide_NN ,_,
          and_CC subsequently_RB processed_VBN by_IN standard_JJ procedures_NNS ._. A_DT few_JJ
          nerves_NNS were_VBD recovered_VBN from_IN eyes_NNS previously_RB embedded_VBN in_IN
          Historesin_NNP (_( Leica_NNP ,_, Heidelberg_NNP ,_, Germany_NNP )_) ._. Cross_NNP sections_NNS
          were_VBD cut_VBN at_IN a_DT thickness_NN of_IN 0_CD ._. 5_CD -_: 1_CD ._. 0_CD μm_NN ,_, stained_JJ with_IN
          Toluidine_NNP Blue_NNP O_NNP ,_, and_CC analyzed_VBD for_IN pathologic_JJ changes_NNS ._.
          Using_VBG this_DT technique_NN ,_, the_DT axoplasm_NN of_IN degenerating_VBG axons_NNS
          appears_VBZ dark_JJ [_NN 53_CD ]_NN ._. The_DT number_NN of_IN females_NNS (_( F_NN )_) and_CC males_NNS
          (_( M_NNP )_) analyzed_VBD at_IN each_DT age_NN (_( in_IN months_NNS )_) were_VBD :_: F_NN 13_CD -_: 14_CD ,_, n_NN =_SYM 3_CD ;_:
          M_NNP 13_CD -_: 14_CD ,_, n_NN =_SYM 13_CD ;_: F_NN 17_CD ,_, n_NN =_SYM 7_CD ;_: M_NNP 17_CD ,_, n_NN =_SYM 5_CD ;_: F_NN 19_CD -_: 20_CD ,_, n_NN =_SYM 12_CD ;_: M_NNP 19_CD -_: 20_CD ,_,
          n_NN =_SYM 10_CD ._. The_DT extent_NN of_IN nerve_NN damage_NN was_VBD independently_RB rated_VBN
          by_IN 3_CD investigators_NNS (_( MGA_NNP ,_, RSS_NNP ,_, SWMJ_NNP )_) who_WP were_VBD unaware_JJ of_IN
          the_DT animals_NNS age_VBP and_CC of_IN each_DT other_JJ 's_POS classification_NN of_IN the_DT
          tissue_NN ._. A_DT single_JJ rating_NN for_IN each_DT sample_NN was_VBD then_RB
          determined_VBN by_IN consensus_NN ,_, although_IN commonly_RB the_DT
          determination_NN was_VBD unanimous_JJ ._. Based_VBN on_IN nerve_NN morphology_NN ,_,
          damage_NN was_VBD rated_VBN using_VBG a_DT broad_JJ scale_NN consisting_VBG of_IN mild_JJ ,_,
          moderate_JJ ,_, and_CC severe_JJ categories_NNS ._. Nerves_NNP estimated_VBD to_TO
          contain_VB 0_CD -_: 25_CD dark_JJ staining_VBG axons_NNS per_IN section_NN and_CC limited_JJ
          or_CC no_DT gliosis_NNS were_VBD rated_VBN as_IN mild_JJ ._. Normal_NNP nerves_NNS with_IN no_DT
          damage_NN were_VBD included_VBN in_IN this_DT category_NN ._. Nerves_NNP estimated_VBD
          to_TO contain_VB greater_JJR than_IN 25_CD dark_JJ staining_VBG axons_NNS per_IN
          section_NN but_CC still_RB maintaining_VBG a_DT significant_JJ portion_NN of_IN
          live_VB axons_NNS were_VBD rated_VBN as_IN moderate_JJ ._. Nerves_NNP rated_VBD as_IN severe_JJ
          contained_VBD numerous_JJ damaged_JJ axons_NNS throughout_IN the_DT nerve_NN ,_,
          had_VBD grossly_RB disrupted_VBN nerve_NN morphology_NN and_CC sometimes_RB
          contained_VBD few_JJ ,_, if_IN any_DT ,_, healthy_JJ axons_NNS ._. Gliosis_NNP was_VBD present_JJ
          in_IN some_DT moderately_RB and_CC severely_RB damaged_JJ nerves_NNS ._.
        
        
          Intraocular_NNP pressure_NN measurement_NN
          IOPs_NNP were_VBD measured_VBN using_VBG a_DT microneedle_NN system_NN as_RB
          previously_RB described_VBD [_NN 11_CD ,_, 54_CD ]_NN ._. The_DT IOPs_NNP of_IN B_NNP 6_CD mice_NNS are_VBP
          consistent_JJ over_IN time_NN and_CC so_IN these_DT animals_NNS were_VBD
          interspersed_VBN with_IN experimental_JJ mice_NNS to_TO ensure_VB that_DT
          calibration_NN had_VBD not_RB drifted_VBD and_CC that_IN the_DT system_NN was_VBD
          functioning_VBG optimally_RB ._. The_DT number_NN of_IN AKXD_NNP 28_CD females_NNS (_( F_NN )_)
          and_CC males_NNS (_( M_NNP )_) successfully_RB analyzed_VBD at_IN each_DT age_NN were_VBD :_:
          F_NN 7_CD -_: 10_CD ,_, n_NN =_SYM 19_CD ;_: M_NNP 7_CD -_: 10_CD ,_, n_NN =_SYM 8_CD ;_: F_NN 11_CD -_: 14_CD ,_, n_NN =_SYM 31_CD ;_: M_NNP 11_CD -_: 14_CD ,_, n_NN =_SYM 21_CD ;_:
          F_NN 15_CD -_: 18_CD ,_, n_NN =_SYM 15_CD ;_: M_NNP 15_CD -_: 18_CD ,_, n_NN =_SYM 12_CD ;_: F_NN 19_CD -_: 21_CD ,_, n_NN =_SYM 12_CD ;_: M_NNP 19_CD -_: 21_CD ,_, n_NN =_SYM 10_CD ._.
          All_DT measurements_NNS were_VBD taken_VBN during_IN the_DT light-on_JJ phase_NN of_IN
          the_DT recording_NN room_NN ._. IOP_NNP values_NNS are_VBP given_VBN as_IN mean_NN ±_NN
          standard_JJ error_NN of_IN the_DT mean_NN ._. Reported_NNP P_NN values_NNS are_VBP from_IN
          multifactorial_NN analysis_NN of_IN variance_NN ._.
        
        
          Measurement_NNP of_IN glutamate_NN levels_NNS
          Aged_NNP mice_NNS were_VBD euthanized_JJ and_CC eyes_NNS removed_VBN ._. Vitreous_NNP
          was_VBD collected_VBN by_IN inserting_VBG a_DT pulled_VBN glass_NN microcapillary_JJ
          needle_NN inserted_VBN approximately_RB midway_NN between_IN the_DT limbus_JJ
          and_CC optic_JJ nerve_NN ,_, and_CC gently_RB pressed_VBN posteriorly_RB into_IN the_DT
          vitreous_JJ at_IN an_DT angle_NN avoiding_VBG the_DT lens_NN and_CC retina_NN ._. This_DT
          technique_NN cleanly_RB collected_VBD the_DT more_RBR liquified_JJ vitreous_JJ ._.
          Pilot_NN experiments_NNS demonstrated_VBN that_IN it_PRP is_VBZ extremely_RB
          difficult_JJ to_TO harvest_NN the_DT more_RBR gelatinous_JJ vitreous_JJ that_WDT is_VBZ
          intricately_RB associated_VBN with_IN the_DT retina_NN without_IN retinal_JJ
          contamination_NN ._. Vitreous_NNP was_VBD collected_VBN under_IN a_DT dissecting_VBG
          microscope_NN and_CC any_DT samples_NNS containing_VBG blood_NN or_CC other_JJ
          visible_JJ debris_NN were_VBD discarded_VBN ._. Collected_NNP vitreous_JJ was_VBD
          immediately_RB transferred_VBN to_TO dry_VB ice_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP
          until_IN processed_VBN ._. Depending_VBG on_IN the_DT amount_NN of_IN vitreous_JJ
          collected_VBN per_IN eye_NN ,_, samples_NNS from_IN 2_CD -_: 4_CD eyes_NNS were_VBD pooled_VBN to_TO
          obtain_VB a_DT total_JJ volume_NN of_IN 10_CD -_: 15_CD μl_NN of_IN vitreous_JJ ._. Sample_NNP
          pools_NNS for_IN female_JJ (_( F_NN )_) and_CC male_JJ (_( M_NNP )_) mice_NNS were_VBD collected_VBN
          from_IN mice_NNS 14_CD and_CC 16_CD months_NNS old_JJ ;_: the_DT number_NN of_IN eyes_NNS
          contributing_VBG to_TO each_DT sample_NN pool_NN was_VBD :_: F_NN 14_CD ,_, n_NN =_SYM 3_CD ;_: M_NNP 14_CD ,_, n_NN =_SYM 3_CD ;_:
          F_NN 16_CD ,_, n_NN =_SYM 2_CD ;_: M_NNP 16_CD ,_, n_NN =_SYM 4_CD ._. Each_DT sample_NN pool_NN was_VBD diluted_VBN to_TO a_DT
          final_JJ volume_NN of_IN 70_CD μl_NN with_IN cold_JJ Beckman_NNP Li-_NNP S_NNP buffer_NN
          (_( 96_CD ._. 8_CD %_NN H_NNP 
          2_CD O_NNP ,_, 1_CD %_NN lithium_NN citrate_NN ,_, 1_CD %_NN
          thiodiglycol_NN ,_, 0_CD ._. 7_CD %_NN hydrogen_NN chloride_NN ,_, 0_CD ._. 5_CD %_NN benzoic_JJ acid_NN ,_,
          pH_NN 2_CD ._. 2_LS )_) ,_, transferred_VBN to_TO an_DT Amicon_NNP 30_CD microconcentrator_NN
          (_( Amicon_NNP Inc_NNP ._. ,_, Beverly_NNP ,_, MA_NNP )_) ,_, and_CC centrifuged_JJ at_IN 16060_CD ×_NN 
          g_SYM for_IN 60_CD minutes_NNS at_IN 4_CD °_NN C_NNP ._. The_DT
          concentrator_NN was_VBD rinsed_JJ with_IN 25_CD μl_NN of_IN Li-_NNP S_NNP buffer_NN and_CC
          centrifuged_JJ for_IN 30_CD minutes_NNS ._. The_DT combined_VBN filtrates_NNS were_VBD
          brought_VBN to_TO a_DT total_JJ volume_NN of_IN 90_CD μl_NN with_IN the_DT same_JJ
          buffer_NN ._.
          The_DT filtrates_NNS were_VBD divided_VBN into_IN two_CD and_CC analyzed_VBD in_IN
          duplicate_VB on_IN a_DT Beckman_NNP 6300_CD Amino_NNP Acid_NNP Analyzer_NNP fitted_JJ
          with_IN a_DT 10_CD cm_NN lithium_NN column_NN and_CC the_DT Beckman_NNP System_NNP Gold_NNP
          data_NNS collection_NN and_CC analysis_NN system_NN (_( Beckman_NNP Instruments_NNP
          Inc_NNP ._. ,_, Palo_NNP Alto_NNP ,_, CA_NNP )_) ._. Values_NNP for_IN each_DT filtrate_NN were_VBD
          determined_VBN from_IN the_DT mean_NN of_IN the_DT duplicate_VB analyses_NNS and_CC
          adjusted_VBN for_IN the_DT original_JJ volume_NN of_IN vitreous_JJ in_IN each_DT
          pool_NN ._. The_DT separation_NN of_IN glutamate_NN and_CC glutamine_NN was_VBD
          achieved_VBN using_VBG Beckman_NNP 's_POS Li-_NNP A_DT buffer_NN (_( 98_CD %_NN H_NNP 
          2_CD O_NNP ,_, 1_CD %_NN lithium_NN citrate_NN ,_, 0_CD ._. 5_CD %_NN lithium_NN
          chloride_NN ,_, 0_CD ._. 5_CD %_NN hydrogen_NN chloride_NN ,_, pH_NN 3_CD ._. 0_CD )_) ._. Standard_JJ
          curves_NNS validating_VBG the_DT method_NN and_CC ensuring_VBG accuracy_NN over_IN
          the_DT experimental_JJ range_NN of_IN concentrations_NNS measured_VBN were_VBD
          generated_VBN using_VBG 5_CD samples_NNS containing_VBG known_VBN quantities_NNS of_IN
          glutamate_NN (_( 50_CD -_: 1000_CD pmoles_NNS )_) and_CC glutamine_NN (_( 100_CD -_: 3200_CD
          pmoles_NNS )_) ._. Values_NNP for_IN glutamate_NN levels_NNS at_IN each_DT age_NN are_VBP
          reported_VBN as_IN mean_NN of_IN the_DT female_JJ and_CC male_JJ sample_NN pools_NNS ±_NN
          the_DT standard_JJ error_NN of_IN the_DT mean_NN ._.
        
      
    
  
